Information contained
on the Hemispherx website other than historical information, should
be considered forward-looking and is subject to various risk factors
and uncertainties. For instance, the strategies and operations of
Hemispherx involve risks of competition, changing market conditions,
changes in laws and regulations affecting these industries and numerous
other factors discussed on the Hemispherx website and in the Company's
filings with the Securities and Exchange Commission. Accordingly,
actual results may differ materially from those in any forward-looking
statements. Additionally, all the referenced investigational drugs
and associated technologies of the company are experimental in nature
and as such are not designated safe and effective by a regulatory
authority for general use and are legally available only through
clinical trials with the referenced disorders. The forward-looking
statements represent the Company's judgement as of the date of this
website. The Company disclaims, however, any intent or obligation
to update these forward-looking statements.
